Human Phenotype Ontology

Input	HPO ID	HPO term	Distance	Gene	Gene id entrez	DiseaseId	DiseaseName	ConceptID	Source	Typical association	ClinVar variants	HGNC ID	GeneMIM
HPO disease - gene - phenotype typical associations:
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0040278	Prolactinoma	2	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0040278	Prolactinoma	2	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0040278	Prolactinoma	2	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0040278	Prolactinoma	2	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0040278	Prolactinoma	2	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0040278	Prolactinoma	2	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0040278	Prolactinoma	2	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0040278	Prolactinoma	2	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0040278	Prolactinoma	2	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0040278	Prolactinoma	2	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0040278	Prolactinoma	2	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0040278	Prolactinoma	2	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0040278	Prolactinoma	2	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0040278	Prolactinoma	2	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0040278	Prolactinoma	2	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0012505	Enlarged pituitary gland	3	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0012506	Small pituitary gland	3	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0010514	Hyperpituitarism	3	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0040075	Hypopituitarism	3	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0010513	Pituitary calcification	3	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0000863	Central diabetes insipidus	3	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0012505	Enlarged pituitary gland	3	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0012506	Small pituitary gland	3	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0010514	Hyperpituitarism	3	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0040075	Hypopituitarism	3	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0010513	Pituitary calcification	3	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0000863	Central diabetes insipidus	3	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0012505	Enlarged pituitary gland	3	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0012506	Small pituitary gland	3	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0010514	Hyperpituitarism	3	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0040075	Hypopituitarism	3	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0010513	Pituitary calcification	3	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0000863	Central diabetes insipidus	3	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0012505	Enlarged pituitary gland	3	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0012506	Small pituitary gland	3	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0010514	Hyperpituitarism	3	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0040075	Hypopituitarism	3	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0010513	Pituitary calcification	3	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0000863	Central diabetes insipidus	3	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0012505	Enlarged pituitary gland	3	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0012506	Small pituitary gland	3	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0010514	Hyperpituitarism	3	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0040075	Hypopituitarism	3	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0010513	Pituitary calcification	3	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0000863	Central diabetes insipidus	3	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0012505	Enlarged pituitary gland	3	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0012506	Small pituitary gland	3	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0010514	Hyperpituitarism	3	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0040075	Hypopituitarism	3	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0010513	Pituitary calcification	3	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0000863	Central diabetes insipidus	3	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0012505	Enlarged pituitary gland	3	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0012506	Small pituitary gland	3	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0010514	Hyperpituitarism	3	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0040075	Hypopituitarism	3	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0010513	Pituitary calcification	3	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0000863	Central diabetes insipidus	3	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0012505	Enlarged pituitary gland	3	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0012506	Small pituitary gland	3	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0010514	Hyperpituitarism	3	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0040075	Hypopituitarism	3	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0010513	Pituitary calcification	3	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0000863	Central diabetes insipidus	3	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0012505	Enlarged pituitary gland	3	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0012506	Small pituitary gland	3	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0010514	Hyperpituitarism	3	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0040075	Hypopituitarism	3	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0010513	Pituitary calcification	3	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0000863	Central diabetes insipidus	3	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0012505	Enlarged pituitary gland	3	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0012506	Small pituitary gland	3	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0010514	Hyperpituitarism	3	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0040075	Hypopituitarism	3	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0010513	Pituitary calcification	3	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0000863	Central diabetes insipidus	3	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0012505	Enlarged pituitary gland	3	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0012506	Small pituitary gland	3	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0010514	Hyperpituitarism	3	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0040075	Hypopituitarism	3	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0010513	Pituitary calcification	3	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0000863	Central diabetes insipidus	3	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0012505	Enlarged pituitary gland	3	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0012506	Small pituitary gland	3	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0010514	Hyperpituitarism	3	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0040075	Hypopituitarism	3	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0010513	Pituitary calcification	3	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0000863	Central diabetes insipidus	3	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0012505	Enlarged pituitary gland	3	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0012506	Small pituitary gland	3	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0010514	Hyperpituitarism	3	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0040075	Hypopituitarism	3	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0010513	Pituitary calcification	3	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0000863	Central diabetes insipidus	3	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0012505	Enlarged pituitary gland	3	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0012506	Small pituitary gland	3	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0010514	Hyperpituitarism	3	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0040075	Hypopituitarism	3	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0010513	Pituitary calcification	3	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0000863	Central diabetes insipidus	3	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0012505	Enlarged pituitary gland	3	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0012506	Small pituitary gland	3	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0010514	Hyperpituitarism	3	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0040075	Hypopituitarism	3	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0010513	Pituitary calcification	3	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0000863	Central diabetes insipidus	3	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0410279	Atrophic pituitary gland	4	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0000830	Anterior hypopituitarism	4	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0002893	Pituitary adenoma	4	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0011763	Pituitary carcinoma	4	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0011754	Pituicytoma	4	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0410279	Atrophic pituitary gland	4	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0000830	Anterior hypopituitarism	4	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0002893	Pituitary adenoma	4	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0011763	Pituitary carcinoma	4	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0011754	Pituicytoma	4	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0410279	Atrophic pituitary gland	4	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0000830	Anterior hypopituitarism	4	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0002893	Pituitary adenoma	4	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0011763	Pituitary carcinoma	4	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0011754	Pituicytoma	4	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0410279	Atrophic pituitary gland	4	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0000830	Anterior hypopituitarism	4	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0002893	Pituitary adenoma	4	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0011763	Pituitary carcinoma	4	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0011754	Pituicytoma	4	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0410279	Atrophic pituitary gland	4	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0000830	Anterior hypopituitarism	4	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0002893	Pituitary adenoma	4	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0011763	Pituitary carcinoma	4	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0011754	Pituicytoma	4	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0410279	Atrophic pituitary gland	4	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0000830	Anterior hypopituitarism	4	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0002893	Pituitary adenoma	4	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0011763	Pituitary carcinoma	4	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0011754	Pituicytoma	4	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0410279	Atrophic pituitary gland	4	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0000830	Anterior hypopituitarism	4	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0002893	Pituitary adenoma	4	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0011763	Pituitary carcinoma	4	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0011754	Pituicytoma	4	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0410279	Atrophic pituitary gland	4	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0000830	Anterior hypopituitarism	4	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0002893	Pituitary adenoma	4	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0011763	Pituitary carcinoma	4	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0011754	Pituicytoma	4	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0410279	Atrophic pituitary gland	4	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0000830	Anterior hypopituitarism	4	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0002893	Pituitary adenoma	4	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0011763	Pituitary carcinoma	4	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0011754	Pituicytoma	4	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0410279	Atrophic pituitary gland	4	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0000830	Anterior hypopituitarism	4	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0002893	Pituitary adenoma	4	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0011763	Pituitary carcinoma	4	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0011754	Pituicytoma	4	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0410279	Atrophic pituitary gland	4	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0000830	Anterior hypopituitarism	4	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0002893	Pituitary adenoma	4	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0011763	Pituitary carcinoma	4	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0011754	Pituicytoma	4	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0410279	Atrophic pituitary gland	4	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0000830	Anterior hypopituitarism	4	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0002893	Pituitary adenoma	4	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0011763	Pituitary carcinoma	4	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0011754	Pituicytoma	4	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0410279	Atrophic pituitary gland	4	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0000830	Anterior hypopituitarism	4	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0002893	Pituitary adenoma	4	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0011763	Pituitary carcinoma	4	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0011754	Pituicytoma	4	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0410279	Atrophic pituitary gland	4	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0000830	Anterior hypopituitarism	4	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0002893	Pituitary adenoma	4	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0011763	Pituitary carcinoma	4	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0011754	Pituicytoma	4	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0410279	Atrophic pituitary gland	4	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0000830	Anterior hypopituitarism	4	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0002893	Pituitary adenoma	4	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0011763	Pituitary carcinoma	4	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0011754	Pituicytoma	4	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0040086	Abnormal prolactin level	5	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0008213	Gonadotropin deficiency	5	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0000871	Panhypopituitarism	5	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0040086	Abnormal prolactin level	5	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0008213	Gonadotropin deficiency	5	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0000871	Panhypopituitarism	5	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0040086	Abnormal prolactin level	5	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0008213	Gonadotropin deficiency	5	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0000871	Panhypopituitarism	5	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0040086	Abnormal prolactin level	5	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0008213	Gonadotropin deficiency	5	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0000871	Panhypopituitarism	5	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0040086	Abnormal prolactin level	5	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0008213	Gonadotropin deficiency	5	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0000871	Panhypopituitarism	5	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0040086	Abnormal prolactin level	5	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0008213	Gonadotropin deficiency	5	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0000871	Panhypopituitarism	5	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0040086	Abnormal prolactin level	5	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0008213	Gonadotropin deficiency	5	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0000871	Panhypopituitarism	5	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0040086	Abnormal prolactin level	5	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0008213	Gonadotropin deficiency	5	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0000871	Panhypopituitarism	5	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0040086	Abnormal prolactin level	5	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0008213	Gonadotropin deficiency	5	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0000871	Panhypopituitarism	5	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0040086	Abnormal prolactin level	5	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0008213	Gonadotropin deficiency	5	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0000871	Panhypopituitarism	5	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0040086	Abnormal prolactin level	5	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0008213	Gonadotropin deficiency	5	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0000871	Panhypopituitarism	5	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0040086	Abnormal prolactin level	5	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0008213	Gonadotropin deficiency	5	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0000871	Panhypopituitarism	5	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0040086	Abnormal prolactin level	5	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0008213	Gonadotropin deficiency	5	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0000871	Panhypopituitarism	5	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0040086	Abnormal prolactin level	5	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0008213	Gonadotropin deficiency	5	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0000871	Panhypopituitarism	5	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0040086	Abnormal prolactin level	5	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0008213	Gonadotropin deficiency	5	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0000871	Panhypopituitarism	5	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0012342	Macroprolactinoma	6	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0012341	Microprolactinoma	6	ANK1 CL E G H	286	251066			ORPHA	1	891	492	612641
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0012342	Macroprolactinoma	6	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0012341	Microprolactinoma	6	CTLA4 CL E G H	1493	900			ORPHA	1	232	2505	123890
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0012342	Macroprolactinoma	6	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0012341	Microprolactinoma	6	HESX1 CL E G H	8820	226307			ORPHA	1	112	4877	601802
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0012342	Macroprolactinoma	6	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0012341	Microprolactinoma	6	HFE CL E G H	3077	465508			ORPHA	1	237	4886	613609
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0012342	Macroprolactinoma	6	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0012341	Microprolactinoma	6	HLA-DPA1 CL E G H	3113	900			ORPHA	1	18	4938	142880
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0012342	Macroprolactinoma	6	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0012341	Microprolactinoma	6	HLA-DPB1 CL E G H	3115	900			ORPHA	1	19	4940	142858
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0012342	Macroprolactinoma	6	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0012341	Microprolactinoma	6	LHX3 CL E G H	8022	226307			ORPHA	1	480	6595	600577
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0012342	Macroprolactinoma	6	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0012341	Microprolactinoma	6	LHX4 CL E G H	89884	226307			ORPHA	1	172	21734	602146
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0012342	Macroprolactinoma	6	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0012341	Microprolactinoma	6	PNPLA6 CL E G H	10908	1173	CDG syndrome type 3		ORPHA	1	1216	16268	603197
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0012342	Macroprolactinoma	6	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0012341	Microprolactinoma	6	POU1F1 CL E G H	5449	226307			ORPHA	1	104	9210	173110
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0012342	Macroprolactinoma	6	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0012341	Microprolactinoma	6	PROP1 CL E G H	5626	226307			ORPHA	1	261	9455	601538
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0012342	Macroprolactinoma	6	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0012341	Microprolactinoma	6	PRTN3 CL E G H	5657	900			ORPHA	1	55	9495	177020
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0012342	Macroprolactinoma	6	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0012341	Microprolactinoma	6	PTPN22 CL E G H	26191	900			ORPHA	1	63	9652	600716
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0012342	Macroprolactinoma	6	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0012341	Microprolactinoma	6	RNF216 CL E G H	54476	1173	CDG syndrome type 3		ORPHA	1	297	21698	609948
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0012342	Macroprolactinoma	6	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HP:0000864	HP:0012341	Microprolactinoma	6	STEAP3 CL E G H	55240	300298			ORPHA	1	94	24592	609671
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0000864	Abnormality of the hypothalamus-pituitary axis	0	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0012285	Abnormal hypothalamus physiology	1	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0012503	Abnormality of the pituitary gland	1	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0040278	Prolactinoma	2	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0040278	Prolactinoma	2	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0040278	Prolactinoma	2	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0040278	Prolactinoma	2	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0040278	Prolactinoma	2	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0040278	Prolactinoma	2	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0040278	Prolactinoma	2	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0040278	Prolactinoma	2	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0040278	Prolactinoma	2	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0040278	Prolactinoma	2	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0040278	Prolactinoma	2	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0040278	Prolactinoma	2	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0040278	Prolactinoma	2	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0040278	Prolactinoma	2	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0040278	Prolactinoma	2	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0040278	Prolactinoma	2	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0040278	Prolactinoma	2	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0040278	Prolactinoma	2	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0040278	Prolactinoma	2	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0040278	Prolactinoma	2	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0040278	Prolactinoma	2	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0040278	Prolactinoma	2	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0040278	Prolactinoma	2	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0040278	Prolactinoma	2	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0040278	Prolactinoma	2	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0040278	Prolactinoma	2	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0040278	Prolactinoma	2	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0040278	Prolactinoma	2	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0040278	Prolactinoma	2	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0040278	Prolactinoma	2	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0040278	Prolactinoma	2	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0040278	Prolactinoma	2	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0040278	Prolactinoma	2	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0040278	Prolactinoma	2	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0040278	Prolactinoma	2	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0040278	Prolactinoma	2	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0040278	Prolactinoma	2	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0040278	Prolactinoma	2	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0040278	Prolactinoma	2	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0040278	Prolactinoma	2	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0040278	Prolactinoma	2	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0040278	Prolactinoma	2	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0040278	Prolactinoma	2	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0040278	Prolactinoma	2	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0040278	Prolactinoma	2	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0040278	Prolactinoma	2	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0040278	Prolactinoma	2	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0040278	Prolactinoma	2	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0040278	Prolactinoma	2	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0040278	Prolactinoma	2	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0040278	Prolactinoma	2	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0040278	Prolactinoma	2	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0040278	Prolactinoma	2	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0040278	Prolactinoma	2	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0040278	Prolactinoma	2	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0040278	Prolactinoma	2	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0040278	Prolactinoma	2	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0040278	Prolactinoma	2	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0040278	Prolactinoma	2	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0040278	Prolactinoma	2	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0040278	Prolactinoma	2	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0040278	Prolactinoma	2	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0040278	Prolactinoma	2	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0040278	Prolactinoma	2	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0040278	Prolactinoma	2	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0040278	Prolactinoma	2	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0003164	Hypothalamic gonadotropin-releasing hormone deficiency	2	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0008237	Hypothalamic hypothyroidism	2	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0012287	Hypothalamic luteinizing hormone-releasing hormone deficiency	2	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0012504	Abnormal size of pituitary gland	2	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0031097	Abnormal thyroid-stimulating hormone level	2	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0011747	Abnormality of the anterior pituitary	2	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0011751	Abnormality of the posterior pituitary	2	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0040278	Prolactinoma	2	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0012505	Enlarged pituitary gland	3	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0012506	Small pituitary gland	3	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0010514	Hyperpituitarism	3	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0040075	Hypopituitarism	3	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0010513	Pituitary calcification	3	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0000863	Central diabetes insipidus	3	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0012505	Enlarged pituitary gland	3	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0012506	Small pituitary gland	3	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0010514	Hyperpituitarism	3	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0040075	Hypopituitarism	3	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0010513	Pituitary calcification	3	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0000863	Central diabetes insipidus	3	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0012505	Enlarged pituitary gland	3	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0012506	Small pituitary gland	3	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0010514	Hyperpituitarism	3	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0040075	Hypopituitarism	3	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0010513	Pituitary calcification	3	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0000863	Central diabetes insipidus	3	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0012505	Enlarged pituitary gland	3	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0012506	Small pituitary gland	3	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0010514	Hyperpituitarism	3	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0040075	Hypopituitarism	3	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0010513	Pituitary calcification	3	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0000863	Central diabetes insipidus	3	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0012505	Enlarged pituitary gland	3	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0012506	Small pituitary gland	3	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0010514	Hyperpituitarism	3	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0040075	Hypopituitarism	3	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0010513	Pituitary calcification	3	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0000863	Central diabetes insipidus	3	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0012505	Enlarged pituitary gland	3	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0012506	Small pituitary gland	3	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0010514	Hyperpituitarism	3	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0040075	Hypopituitarism	3	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0010513	Pituitary calcification	3	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0000863	Central diabetes insipidus	3	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0012505	Enlarged pituitary gland	3	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0012506	Small pituitary gland	3	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0010514	Hyperpituitarism	3	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0040075	Hypopituitarism	3	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0010513	Pituitary calcification	3	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0000863	Central diabetes insipidus	3	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0012505	Enlarged pituitary gland	3	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0012506	Small pituitary gland	3	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0010514	Hyperpituitarism	3	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0040075	Hypopituitarism	3	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0010513	Pituitary calcification	3	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0000863	Central diabetes insipidus	3	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0012505	Enlarged pituitary gland	3	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0012506	Small pituitary gland	3	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0010514	Hyperpituitarism	3	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0040075	Hypopituitarism	3	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0010513	Pituitary calcification	3	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0000863	Central diabetes insipidus	3	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0012505	Enlarged pituitary gland	3	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0012506	Small pituitary gland	3	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0010514	Hyperpituitarism	3	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0040075	Hypopituitarism	3	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0010513	Pituitary calcification	3	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0000863	Central diabetes insipidus	3	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0012505	Enlarged pituitary gland	3	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0012506	Small pituitary gland	3	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0010514	Hyperpituitarism	3	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0040075	Hypopituitarism	3	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0010513	Pituitary calcification	3	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0000863	Central diabetes insipidus	3	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0012505	Enlarged pituitary gland	3	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0012506	Small pituitary gland	3	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0010514	Hyperpituitarism	3	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0040075	Hypopituitarism	3	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0010513	Pituitary calcification	3	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0000863	Central diabetes insipidus	3	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0012505	Enlarged pituitary gland	3	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0012506	Small pituitary gland	3	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0010514	Hyperpituitarism	3	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0040075	Hypopituitarism	3	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0010513	Pituitary calcification	3	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0000863	Central diabetes insipidus	3	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0012505	Enlarged pituitary gland	3	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0012506	Small pituitary gland	3	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0010514	Hyperpituitarism	3	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0040075	Hypopituitarism	3	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0010513	Pituitary calcification	3	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0000863	Central diabetes insipidus	3	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0012505	Enlarged pituitary gland	3	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0012506	Small pituitary gland	3	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0010514	Hyperpituitarism	3	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0040075	Hypopituitarism	3	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0010513	Pituitary calcification	3	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0000863	Central diabetes insipidus	3	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0012505	Enlarged pituitary gland	3	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0012506	Small pituitary gland	3	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0010514	Hyperpituitarism	3	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0040075	Hypopituitarism	3	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0010513	Pituitary calcification	3	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0000863	Central diabetes insipidus	3	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0012505	Enlarged pituitary gland	3	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0012506	Small pituitary gland	3	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0010514	Hyperpituitarism	3	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0040075	Hypopituitarism	3	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0010513	Pituitary calcification	3	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0000863	Central diabetes insipidus	3	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0012505	Enlarged pituitary gland	3	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0012506	Small pituitary gland	3	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0010514	Hyperpituitarism	3	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0040075	Hypopituitarism	3	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0010513	Pituitary calcification	3	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0000863	Central diabetes insipidus	3	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0012505	Enlarged pituitary gland	3	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0012506	Small pituitary gland	3	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0010514	Hyperpituitarism	3	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0040075	Hypopituitarism	3	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0010513	Pituitary calcification	3	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0000863	Central diabetes insipidus	3	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0012505	Enlarged pituitary gland	3	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0012506	Small pituitary gland	3	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0010514	Hyperpituitarism	3	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0040075	Hypopituitarism	3	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0010513	Pituitary calcification	3	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0000863	Central diabetes insipidus	3	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0012505	Enlarged pituitary gland	3	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0012506	Small pituitary gland	3	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0010514	Hyperpituitarism	3	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0040075	Hypopituitarism	3	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0010513	Pituitary calcification	3	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0000863	Central diabetes insipidus	3	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0012505	Enlarged pituitary gland	3	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0012506	Small pituitary gland	3	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0010514	Hyperpituitarism	3	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0040075	Hypopituitarism	3	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0010513	Pituitary calcification	3	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0000863	Central diabetes insipidus	3	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0012505	Enlarged pituitary gland	3	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0012506	Small pituitary gland	3	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0010514	Hyperpituitarism	3	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0040075	Hypopituitarism	3	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0010513	Pituitary calcification	3	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0000863	Central diabetes insipidus	3	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0012505	Enlarged pituitary gland	3	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0012506	Small pituitary gland	3	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0010514	Hyperpituitarism	3	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0040075	Hypopituitarism	3	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0010513	Pituitary calcification	3	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0000863	Central diabetes insipidus	3	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0012505	Enlarged pituitary gland	3	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0012506	Small pituitary gland	3	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0010514	Hyperpituitarism	3	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0040075	Hypopituitarism	3	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0010513	Pituitary calcification	3	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0000863	Central diabetes insipidus	3	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0012505	Enlarged pituitary gland	3	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0012506	Small pituitary gland	3	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0010514	Hyperpituitarism	3	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0040075	Hypopituitarism	3	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0010513	Pituitary calcification	3	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0000863	Central diabetes insipidus	3	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0012505	Enlarged pituitary gland	3	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0012506	Small pituitary gland	3	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0010514	Hyperpituitarism	3	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0040075	Hypopituitarism	3	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0010513	Pituitary calcification	3	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0000863	Central diabetes insipidus	3	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0012505	Enlarged pituitary gland	3	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0012506	Small pituitary gland	3	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0010514	Hyperpituitarism	3	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0040075	Hypopituitarism	3	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0010513	Pituitary calcification	3	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0000863	Central diabetes insipidus	3	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0012505	Enlarged pituitary gland	3	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0012506	Small pituitary gland	3	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0010514	Hyperpituitarism	3	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0040075	Hypopituitarism	3	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0010513	Pituitary calcification	3	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0000863	Central diabetes insipidus	3	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0012505	Enlarged pituitary gland	3	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0012506	Small pituitary gland	3	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0010514	Hyperpituitarism	3	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0040075	Hypopituitarism	3	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0010513	Pituitary calcification	3	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0000863	Central diabetes insipidus	3	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0012505	Enlarged pituitary gland	3	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0012506	Small pituitary gland	3	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0010514	Hyperpituitarism	3	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0040075	Hypopituitarism	3	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0010513	Pituitary calcification	3	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0000863	Central diabetes insipidus	3	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0012505	Enlarged pituitary gland	3	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0012506	Small pituitary gland	3	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0010514	Hyperpituitarism	3	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0040075	Hypopituitarism	3	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0010513	Pituitary calcification	3	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0000863	Central diabetes insipidus	3	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0012505	Enlarged pituitary gland	3	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0012506	Small pituitary gland	3	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0010514	Hyperpituitarism	3	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0040075	Hypopituitarism	3	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0010513	Pituitary calcification	3	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0000863	Central diabetes insipidus	3	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0012505	Enlarged pituitary gland	3	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0012506	Small pituitary gland	3	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0010514	Hyperpituitarism	3	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0040075	Hypopituitarism	3	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0010513	Pituitary calcification	3	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0000863	Central diabetes insipidus	3	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0012505	Enlarged pituitary gland	3	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0012506	Small pituitary gland	3	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0010514	Hyperpituitarism	3	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0040075	Hypopituitarism	3	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0010513	Pituitary calcification	3	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0000863	Central diabetes insipidus	3	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0012505	Enlarged pituitary gland	3	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0012506	Small pituitary gland	3	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0010514	Hyperpituitarism	3	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0040075	Hypopituitarism	3	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0010513	Pituitary calcification	3	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0000863	Central diabetes insipidus	3	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0012505	Enlarged pituitary gland	3	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0012506	Small pituitary gland	3	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0010514	Hyperpituitarism	3	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0040075	Hypopituitarism	3	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0010513	Pituitary calcification	3	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0000863	Central diabetes insipidus	3	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0012505	Enlarged pituitary gland	3	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0012506	Small pituitary gland	3	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0010514	Hyperpituitarism	3	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0040075	Hypopituitarism	3	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0010513	Pituitary calcification	3	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0000863	Central diabetes insipidus	3	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0012505	Enlarged pituitary gland	3	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0012506	Small pituitary gland	3	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0010514	Hyperpituitarism	3	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0040075	Hypopituitarism	3	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0010513	Pituitary calcification	3	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0000863	Central diabetes insipidus	3	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0012505	Enlarged pituitary gland	3	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0012506	Small pituitary gland	3	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0010514	Hyperpituitarism	3	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0040075	Hypopituitarism	3	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0010513	Pituitary calcification	3	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0000863	Central diabetes insipidus	3	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0012505	Enlarged pituitary gland	3	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0012506	Small pituitary gland	3	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0010514	Hyperpituitarism	3	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0040075	Hypopituitarism	3	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0010513	Pituitary calcification	3	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0000863	Central diabetes insipidus	3	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0012505	Enlarged pituitary gland	3	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0012506	Small pituitary gland	3	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0010514	Hyperpituitarism	3	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0040075	Hypopituitarism	3	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0010513	Pituitary calcification	3	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0000863	Central diabetes insipidus	3	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0012505	Enlarged pituitary gland	3	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0012506	Small pituitary gland	3	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0010514	Hyperpituitarism	3	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0040075	Hypopituitarism	3	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0010513	Pituitary calcification	3	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0000863	Central diabetes insipidus	3	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0012505	Enlarged pituitary gland	3	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0012506	Small pituitary gland	3	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0010514	Hyperpituitarism	3	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0040075	Hypopituitarism	3	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0010513	Pituitary calcification	3	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0000863	Central diabetes insipidus	3	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0012505	Enlarged pituitary gland	3	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0012506	Small pituitary gland	3	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0010514	Hyperpituitarism	3	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0040075	Hypopituitarism	3	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0010513	Pituitary calcification	3	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0000863	Central diabetes insipidus	3	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0012505	Enlarged pituitary gland	3	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0012506	Small pituitary gland	3	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0010514	Hyperpituitarism	3	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0040075	Hypopituitarism	3	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0010513	Pituitary calcification	3	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0000863	Central diabetes insipidus	3	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0012505	Enlarged pituitary gland	3	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0012506	Small pituitary gland	3	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0010514	Hyperpituitarism	3	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0040075	Hypopituitarism	3	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0010513	Pituitary calcification	3	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0000863	Central diabetes insipidus	3	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0012505	Enlarged pituitary gland	3	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0012506	Small pituitary gland	3	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0010514	Hyperpituitarism	3	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0040075	Hypopituitarism	3	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0010513	Pituitary calcification	3	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0000863	Central diabetes insipidus	3	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0012505	Enlarged pituitary gland	3	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0012506	Small pituitary gland	3	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0010514	Hyperpituitarism	3	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0040075	Hypopituitarism	3	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0010513	Pituitary calcification	3	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0000863	Central diabetes insipidus	3	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0012505	Enlarged pituitary gland	3	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0012506	Small pituitary gland	3	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0010514	Hyperpituitarism	3	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0040075	Hypopituitarism	3	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0010513	Pituitary calcification	3	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0000863	Central diabetes insipidus	3	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0012505	Enlarged pituitary gland	3	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0012506	Small pituitary gland	3	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0010514	Hyperpituitarism	3	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0040075	Hypopituitarism	3	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0010513	Pituitary calcification	3	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0000863	Central diabetes insipidus	3	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0012505	Enlarged pituitary gland	3	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0012506	Small pituitary gland	3	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0010514	Hyperpituitarism	3	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0040075	Hypopituitarism	3	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0010513	Pituitary calcification	3	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0000863	Central diabetes insipidus	3	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0012505	Enlarged pituitary gland	3	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0012506	Small pituitary gland	3	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0010514	Hyperpituitarism	3	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0040075	Hypopituitarism	3	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0010513	Pituitary calcification	3	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0000863	Central diabetes insipidus	3	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0012505	Enlarged pituitary gland	3	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0012506	Small pituitary gland	3	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0010514	Hyperpituitarism	3	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0040075	Hypopituitarism	3	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0010513	Pituitary calcification	3	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0000863	Central diabetes insipidus	3	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0012505	Enlarged pituitary gland	3	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0012506	Small pituitary gland	3	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0010514	Hyperpituitarism	3	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0040075	Hypopituitarism	3	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0010513	Pituitary calcification	3	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0000863	Central diabetes insipidus	3	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0012505	Enlarged pituitary gland	3	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0012506	Small pituitary gland	3	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0010514	Hyperpituitarism	3	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0040075	Hypopituitarism	3	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0010513	Pituitary calcification	3	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0000863	Central diabetes insipidus	3	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0012505	Enlarged pituitary gland	3	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0012506	Small pituitary gland	3	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0010514	Hyperpituitarism	3	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0040075	Hypopituitarism	3	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0010513	Pituitary calcification	3	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0000863	Central diabetes insipidus	3	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0012505	Enlarged pituitary gland	3	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0012506	Small pituitary gland	3	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0010514	Hyperpituitarism	3	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0040075	Hypopituitarism	3	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0010513	Pituitary calcification	3	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0000863	Central diabetes insipidus	3	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0012505	Enlarged pituitary gland	3	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0012506	Small pituitary gland	3	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0010514	Hyperpituitarism	3	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0040075	Hypopituitarism	3	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0010513	Pituitary calcification	3	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0000863	Central diabetes insipidus	3	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0012505	Enlarged pituitary gland	3	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0012506	Small pituitary gland	3	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0010514	Hyperpituitarism	3	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0040075	Hypopituitarism	3	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0010513	Pituitary calcification	3	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0000863	Central diabetes insipidus	3	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0012505	Enlarged pituitary gland	3	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0012506	Small pituitary gland	3	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0010514	Hyperpituitarism	3	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0040075	Hypopituitarism	3	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0010513	Pituitary calcification	3	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0000863	Central diabetes insipidus	3	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0012505	Enlarged pituitary gland	3	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0012506	Small pituitary gland	3	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0010514	Hyperpituitarism	3	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0040075	Hypopituitarism	3	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0010513	Pituitary calcification	3	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0000863	Central diabetes insipidus	3	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0012505	Enlarged pituitary gland	3	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0012506	Small pituitary gland	3	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0010514	Hyperpituitarism	3	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0040075	Hypopituitarism	3	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0010513	Pituitary calcification	3	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0000863	Central diabetes insipidus	3	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0012505	Enlarged pituitary gland	3	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0012506	Small pituitary gland	3	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0010514	Hyperpituitarism	3	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0040075	Hypopituitarism	3	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0010513	Pituitary calcification	3	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0000863	Central diabetes insipidus	3	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0012505	Enlarged pituitary gland	3	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0012506	Small pituitary gland	3	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0010514	Hyperpituitarism	3	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0040075	Hypopituitarism	3	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0010513	Pituitary calcification	3	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0000863	Central diabetes insipidus	3	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0012505	Enlarged pituitary gland	3	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0012506	Small pituitary gland	3	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0010514	Hyperpituitarism	3	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0040075	Hypopituitarism	3	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0010513	Pituitary calcification	3	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0000863	Central diabetes insipidus	3	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0012505	Enlarged pituitary gland	3	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0012506	Small pituitary gland	3	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0031098	Decreased thyroid-stimulating hormone level	3	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0002925	Elevated circulating thyroid-stimulating hormone concentration	3	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0033075	Inappropriately normal thyroid-stimulating hormone level	3	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0010625	Anterior pituitary dysgenesis	3	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0012731	Ectopic anterior pituitary gland	3	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0010514	Hyperpituitarism	3	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0040075	Hypopituitarism	3	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0011750	Neoplasm of the anterior pituitary	3	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0010513	Pituitary calcification	3	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0008227	Pituitary resistance to thyroid hormone	3	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0000863	Central diabetes insipidus	3	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0011752	Neoplasm of the posterior pituitary	3	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0011753	Posterior pituitary dysgenesis	3	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0410279	Atrophic pituitary gland	4	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0000830	Anterior hypopituitarism	4	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0002893	Pituitary adenoma	4	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0011763	Pituitary carcinoma	4	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0011754	Pituicytoma	4	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0410279	Atrophic pituitary gland	4	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0000830	Anterior hypopituitarism	4	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0002893	Pituitary adenoma	4	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0011763	Pituitary carcinoma	4	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0011754	Pituicytoma	4	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0410279	Atrophic pituitary gland	4	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0000830	Anterior hypopituitarism	4	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0002893	Pituitary adenoma	4	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0011763	Pituitary carcinoma	4	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0011754	Pituicytoma	4	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0410279	Atrophic pituitary gland	4	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0000830	Anterior hypopituitarism	4	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0002893	Pituitary adenoma	4	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0011763	Pituitary carcinoma	4	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0011754	Pituicytoma	4	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0410279	Atrophic pituitary gland	4	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0000830	Anterior hypopituitarism	4	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0002893	Pituitary adenoma	4	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0011763	Pituitary carcinoma	4	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0011754	Pituicytoma	4	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0410279	Atrophic pituitary gland	4	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0000830	Anterior hypopituitarism	4	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0002893	Pituitary adenoma	4	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0011763	Pituitary carcinoma	4	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0011754	Pituicytoma	4	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0410279	Atrophic pituitary gland	4	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0000830	Anterior hypopituitarism	4	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0002893	Pituitary adenoma	4	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0011763	Pituitary carcinoma	4	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0011754	Pituicytoma	4	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0410279	Atrophic pituitary gland	4	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0000830	Anterior hypopituitarism	4	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0002893	Pituitary adenoma	4	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0011763	Pituitary carcinoma	4	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0011754	Pituicytoma	4	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0410279	Atrophic pituitary gland	4	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0000830	Anterior hypopituitarism	4	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0002893	Pituitary adenoma	4	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0011763	Pituitary carcinoma	4	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0011754	Pituicytoma	4	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0410279	Atrophic pituitary gland	4	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0000830	Anterior hypopituitarism	4	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0002893	Pituitary adenoma	4	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0011763	Pituitary carcinoma	4	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0011754	Pituicytoma	4	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0410279	Atrophic pituitary gland	4	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0000830	Anterior hypopituitarism	4	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0002893	Pituitary adenoma	4	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0011763	Pituitary carcinoma	4	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0011754	Pituicytoma	4	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0410279	Atrophic pituitary gland	4	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0000830	Anterior hypopituitarism	4	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0002893	Pituitary adenoma	4	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0011763	Pituitary carcinoma	4	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0011754	Pituicytoma	4	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0410279	Atrophic pituitary gland	4	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0000830	Anterior hypopituitarism	4	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0002893	Pituitary adenoma	4	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0011763	Pituitary carcinoma	4	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0011754	Pituicytoma	4	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0410279	Atrophic pituitary gland	4	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0000830	Anterior hypopituitarism	4	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0002893	Pituitary adenoma	4	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0011763	Pituitary carcinoma	4	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0011754	Pituicytoma	4	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0410279	Atrophic pituitary gland	4	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0000830	Anterior hypopituitarism	4	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0002893	Pituitary adenoma	4	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0011763	Pituitary carcinoma	4	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0011754	Pituicytoma	4	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0410279	Atrophic pituitary gland	4	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0000830	Anterior hypopituitarism	4	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0002893	Pituitary adenoma	4	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0011763	Pituitary carcinoma	4	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0011754	Pituicytoma	4	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0410279	Atrophic pituitary gland	4	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0000830	Anterior hypopituitarism	4	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0002893	Pituitary adenoma	4	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0011763	Pituitary carcinoma	4	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0011754	Pituicytoma	4	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0410279	Atrophic pituitary gland	4	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0000830	Anterior hypopituitarism	4	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0002893	Pituitary adenoma	4	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0011763	Pituitary carcinoma	4	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0011754	Pituicytoma	4	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0410279	Atrophic pituitary gland	4	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0000830	Anterior hypopituitarism	4	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0002893	Pituitary adenoma	4	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0011763	Pituitary carcinoma	4	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0011754	Pituicytoma	4	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0410279	Atrophic pituitary gland	4	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0000830	Anterior hypopituitarism	4	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0002893	Pituitary adenoma	4	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0011763	Pituitary carcinoma	4	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0011754	Pituicytoma	4	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0410279	Atrophic pituitary gland	4	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0000830	Anterior hypopituitarism	4	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0002893	Pituitary adenoma	4	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0011763	Pituitary carcinoma	4	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0011754	Pituicytoma	4	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0410279	Atrophic pituitary gland	4	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0000830	Anterior hypopituitarism	4	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0002893	Pituitary adenoma	4	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0011763	Pituitary carcinoma	4	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0011754	Pituicytoma	4	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0410279	Atrophic pituitary gland	4	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0000830	Anterior hypopituitarism	4	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0002893	Pituitary adenoma	4	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0011763	Pituitary carcinoma	4	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0011754	Pituicytoma	4	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0410279	Atrophic pituitary gland	4	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0000830	Anterior hypopituitarism	4	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0002893	Pituitary adenoma	4	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0011763	Pituitary carcinoma	4	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0011754	Pituicytoma	4	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0410279	Atrophic pituitary gland	4	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0000830	Anterior hypopituitarism	4	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0002893	Pituitary adenoma	4	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0011763	Pituitary carcinoma	4	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0011754	Pituicytoma	4	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0410279	Atrophic pituitary gland	4	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0000830	Anterior hypopituitarism	4	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0002893	Pituitary adenoma	4	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0011763	Pituitary carcinoma	4	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0011754	Pituicytoma	4	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0410279	Atrophic pituitary gland	4	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0000830	Anterior hypopituitarism	4	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0002893	Pituitary adenoma	4	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0011763	Pituitary carcinoma	4	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0011754	Pituicytoma	4	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0410279	Atrophic pituitary gland	4	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0000830	Anterior hypopituitarism	4	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0002893	Pituitary adenoma	4	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0011763	Pituitary carcinoma	4	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0011754	Pituicytoma	4	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0410279	Atrophic pituitary gland	4	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0000830	Anterior hypopituitarism	4	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0002893	Pituitary adenoma	4	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0011763	Pituitary carcinoma	4	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0011754	Pituicytoma	4	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0410279	Atrophic pituitary gland	4	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0000830	Anterior hypopituitarism	4	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0002893	Pituitary adenoma	4	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0011763	Pituitary carcinoma	4	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0011754	Pituicytoma	4	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0410279	Atrophic pituitary gland	4	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0000830	Anterior hypopituitarism	4	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0002893	Pituitary adenoma	4	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0011763	Pituitary carcinoma	4	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0011754	Pituicytoma	4	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0410279	Atrophic pituitary gland	4	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0000830	Anterior hypopituitarism	4	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0002893	Pituitary adenoma	4	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0011763	Pituitary carcinoma	4	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0011754	Pituicytoma	4	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0410279	Atrophic pituitary gland	4	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0000830	Anterior hypopituitarism	4	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0002893	Pituitary adenoma	4	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0011763	Pituitary carcinoma	4	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0011754	Pituicytoma	4	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0410279	Atrophic pituitary gland	4	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0000830	Anterior hypopituitarism	4	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0002893	Pituitary adenoma	4	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0011763	Pituitary carcinoma	4	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0011754	Pituicytoma	4	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0410279	Atrophic pituitary gland	4	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0000830	Anterior hypopituitarism	4	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0002893	Pituitary adenoma	4	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0011763	Pituitary carcinoma	4	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0011754	Pituicytoma	4	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0410279	Atrophic pituitary gland	4	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0000830	Anterior hypopituitarism	4	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0002893	Pituitary adenoma	4	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0011763	Pituitary carcinoma	4	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0011754	Pituicytoma	4	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0410279	Atrophic pituitary gland	4	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0000830	Anterior hypopituitarism	4	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0002893	Pituitary adenoma	4	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0011763	Pituitary carcinoma	4	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0011754	Pituicytoma	4	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0410279	Atrophic pituitary gland	4	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0000830	Anterior hypopituitarism	4	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0002893	Pituitary adenoma	4	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0011763	Pituitary carcinoma	4	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0011754	Pituicytoma	4	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0410279	Atrophic pituitary gland	4	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0000830	Anterior hypopituitarism	4	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0002893	Pituitary adenoma	4	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0011763	Pituitary carcinoma	4	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0011754	Pituicytoma	4	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0410279	Atrophic pituitary gland	4	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0000830	Anterior hypopituitarism	4	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0002893	Pituitary adenoma	4	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0011763	Pituitary carcinoma	4	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0011754	Pituicytoma	4	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0410279	Atrophic pituitary gland	4	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0000830	Anterior hypopituitarism	4	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0002893	Pituitary adenoma	4	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0011763	Pituitary carcinoma	4	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0011754	Pituicytoma	4	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0410279	Atrophic pituitary gland	4	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0000830	Anterior hypopituitarism	4	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0002893	Pituitary adenoma	4	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0011763	Pituitary carcinoma	4	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0011754	Pituicytoma	4	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0410279	Atrophic pituitary gland	4	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0000830	Anterior hypopituitarism	4	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0002893	Pituitary adenoma	4	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0011763	Pituitary carcinoma	4	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0011754	Pituicytoma	4	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0410279	Atrophic pituitary gland	4	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0000830	Anterior hypopituitarism	4	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0002893	Pituitary adenoma	4	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0011763	Pituitary carcinoma	4	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0011754	Pituicytoma	4	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0410279	Atrophic pituitary gland	4	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0000830	Anterior hypopituitarism	4	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0002893	Pituitary adenoma	4	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0011763	Pituitary carcinoma	4	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0011754	Pituicytoma	4	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0410279	Atrophic pituitary gland	4	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0000830	Anterior hypopituitarism	4	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0002893	Pituitary adenoma	4	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0011763	Pituitary carcinoma	4	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0011754	Pituicytoma	4	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0410279	Atrophic pituitary gland	4	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0000830	Anterior hypopituitarism	4	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0002893	Pituitary adenoma	4	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0011763	Pituitary carcinoma	4	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0011754	Pituicytoma	4	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0410279	Atrophic pituitary gland	4	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0000830	Anterior hypopituitarism	4	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0002893	Pituitary adenoma	4	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0011763	Pituitary carcinoma	4	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0011754	Pituicytoma	4	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0410279	Atrophic pituitary gland	4	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0000830	Anterior hypopituitarism	4	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0002893	Pituitary adenoma	4	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0011763	Pituitary carcinoma	4	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0011754	Pituicytoma	4	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0410279	Atrophic pituitary gland	4	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0000830	Anterior hypopituitarism	4	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0002893	Pituitary adenoma	4	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0011763	Pituitary carcinoma	4	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0011754	Pituicytoma	4	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0410279	Atrophic pituitary gland	4	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0000830	Anterior hypopituitarism	4	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0002893	Pituitary adenoma	4	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0011763	Pituitary carcinoma	4	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0011754	Pituicytoma	4	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0410279	Atrophic pituitary gland	4	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0000830	Anterior hypopituitarism	4	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0002893	Pituitary adenoma	4	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0011763	Pituitary carcinoma	4	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0011754	Pituicytoma	4	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0410279	Atrophic pituitary gland	4	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0000830	Anterior hypopituitarism	4	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0002893	Pituitary adenoma	4	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0011763	Pituitary carcinoma	4	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0011754	Pituicytoma	4	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0410279	Atrophic pituitary gland	4	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0000830	Anterior hypopituitarism	4	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0002893	Pituitary adenoma	4	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0011763	Pituitary carcinoma	4	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0011754	Pituicytoma	4	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0410279	Atrophic pituitary gland	4	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0000830	Anterior hypopituitarism	4	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0002893	Pituitary adenoma	4	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0011763	Pituitary carcinoma	4	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0011754	Pituicytoma	4	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0410279	Atrophic pituitary gland	4	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0000830	Anterior hypopituitarism	4	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0002893	Pituitary adenoma	4	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0011763	Pituitary carcinoma	4	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0011754	Pituicytoma	4	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0410279	Atrophic pituitary gland	4	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0000830	Anterior hypopituitarism	4	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0002893	Pituitary adenoma	4	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0011763	Pituitary carcinoma	4	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0011754	Pituicytoma	4	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0410279	Atrophic pituitary gland	4	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0000830	Anterior hypopituitarism	4	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0002893	Pituitary adenoma	4	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0011763	Pituitary carcinoma	4	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0011754	Pituicytoma	4	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0410279	Atrophic pituitary gland	4	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0000830	Anterior hypopituitarism	4	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0002893	Pituitary adenoma	4	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0011763	Pituitary carcinoma	4	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0011754	Pituicytoma	4	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0410279	Atrophic pituitary gland	4	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0000830	Anterior hypopituitarism	4	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0002893	Pituitary adenoma	4	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0011763	Pituitary carcinoma	4	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0011754	Pituicytoma	4	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0410279	Atrophic pituitary gland	4	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0000830	Anterior hypopituitarism	4	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0002893	Pituitary adenoma	4	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0011763	Pituitary carcinoma	4	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0011754	Pituicytoma	4	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0410279	Atrophic pituitary gland	4	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0000830	Anterior hypopituitarism	4	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0002893	Pituitary adenoma	4	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0011763	Pituitary carcinoma	4	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0011754	Pituicytoma	4	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0410279	Atrophic pituitary gland	4	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0000830	Anterior hypopituitarism	4	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0002893	Pituitary adenoma	4	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0011763	Pituitary carcinoma	4	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0011754	Pituicytoma	4	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0410279	Atrophic pituitary gland	4	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0000830	Anterior hypopituitarism	4	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0002893	Pituitary adenoma	4	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0011763	Pituitary carcinoma	4	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0011754	Pituicytoma	4	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0410279	Atrophic pituitary gland	4	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0000830	Anterior hypopituitarism	4	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0002893	Pituitary adenoma	4	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0011763	Pituitary carcinoma	4	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0011754	Pituicytoma	4	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0410279	Atrophic pituitary gland	4	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0000830	Anterior hypopituitarism	4	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0002893	Pituitary adenoma	4	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0011763	Pituitary carcinoma	4	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0011754	Pituicytoma	4	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0000837	Increased circulating gonadotropin level	4	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0000845	Elevated circulating growth hormone concentration	4	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0410279	Atrophic pituitary gland	4	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0010626	Anterior pituitary agenesis	4	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0010627	Anterior pituitary hypoplasia	4	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0011749	Adrenocorticotropic hormone excess	4	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0000870	Increased circulating prolactin concentration	4	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0000830	Anterior hypopituitarism	4	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0002893	Pituitary adenoma	4	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0011763	Pituitary carcinoma	4	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0011764	Pituitary spindle cell oncocytoma	4	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0011754	Pituicytoma	4	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0011755	Ectopic posterior pituitary	4	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0011756	Posterior pituitary agenesis	4	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0011757	Posterior pituitary hypoplasia	4	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0040086	Abnormal prolactin level	5	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0008213	Gonadotropin deficiency	5	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0000871	Panhypopituitarism	5	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0040086	Abnormal prolactin level	5	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0008213	Gonadotropin deficiency	5	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0000871	Panhypopituitarism	5	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0040086	Abnormal prolactin level	5	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0008213	Gonadotropin deficiency	5	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0000871	Panhypopituitarism	5	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0040086	Abnormal prolactin level	5	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0008213	Gonadotropin deficiency	5	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0000871	Panhypopituitarism	5	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0040086	Abnormal prolactin level	5	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0008213	Gonadotropin deficiency	5	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0000871	Panhypopituitarism	5	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0040086	Abnormal prolactin level	5	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0008213	Gonadotropin deficiency	5	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0000871	Panhypopituitarism	5	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0040086	Abnormal prolactin level	5	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0008213	Gonadotropin deficiency	5	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0000871	Panhypopituitarism	5	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0040086	Abnormal prolactin level	5	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0008213	Gonadotropin deficiency	5	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0000871	Panhypopituitarism	5	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0040086	Abnormal prolactin level	5	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0008213	Gonadotropin deficiency	5	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0000871	Panhypopituitarism	5	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0040086	Abnormal prolactin level	5	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0008213	Gonadotropin deficiency	5	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0000871	Panhypopituitarism	5	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0040086	Abnormal prolactin level	5	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0008213	Gonadotropin deficiency	5	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0000871	Panhypopituitarism	5	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0040086	Abnormal prolactin level	5	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0008213	Gonadotropin deficiency	5	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0000871	Panhypopituitarism	5	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0040086	Abnormal prolactin level	5	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0008213	Gonadotropin deficiency	5	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0000871	Panhypopituitarism	5	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0040086	Abnormal prolactin level	5	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0008213	Gonadotropin deficiency	5	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0000871	Panhypopituitarism	5	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0040086	Abnormal prolactin level	5	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0008213	Gonadotropin deficiency	5	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0000871	Panhypopituitarism	5	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0040086	Abnormal prolactin level	5	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0008213	Gonadotropin deficiency	5	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0000871	Panhypopituitarism	5	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0040086	Abnormal prolactin level	5	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0008213	Gonadotropin deficiency	5	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0000871	Panhypopituitarism	5	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0040086	Abnormal prolactin level	5	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0008213	Gonadotropin deficiency	5	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0000871	Panhypopituitarism	5	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0040086	Abnormal prolactin level	5	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0008213	Gonadotropin deficiency	5	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0000871	Panhypopituitarism	5	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0040086	Abnormal prolactin level	5	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0008213	Gonadotropin deficiency	5	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0000871	Panhypopituitarism	5	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0040086	Abnormal prolactin level	5	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0008213	Gonadotropin deficiency	5	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0000871	Panhypopituitarism	5	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0040086	Abnormal prolactin level	5	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0008213	Gonadotropin deficiency	5	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0000871	Panhypopituitarism	5	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0040086	Abnormal prolactin level	5	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0008213	Gonadotropin deficiency	5	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0000871	Panhypopituitarism	5	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0040086	Abnormal prolactin level	5	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0008213	Gonadotropin deficiency	5	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0000871	Panhypopituitarism	5	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0040086	Abnormal prolactin level	5	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0008213	Gonadotropin deficiency	5	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0000871	Panhypopituitarism	5	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0040086	Abnormal prolactin level	5	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0008213	Gonadotropin deficiency	5	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0000871	Panhypopituitarism	5	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0040086	Abnormal prolactin level	5	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0008213	Gonadotropin deficiency	5	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0000871	Panhypopituitarism	5	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0040086	Abnormal prolactin level	5	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0008213	Gonadotropin deficiency	5	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0000871	Panhypopituitarism	5	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0040086	Abnormal prolactin level	5	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0008213	Gonadotropin deficiency	5	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0000871	Panhypopituitarism	5	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0040086	Abnormal prolactin level	5	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0008213	Gonadotropin deficiency	5	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0000871	Panhypopituitarism	5	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0040086	Abnormal prolactin level	5	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0008213	Gonadotropin deficiency	5	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0000871	Panhypopituitarism	5	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0040086	Abnormal prolactin level	5	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0008213	Gonadotropin deficiency	5	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0000871	Panhypopituitarism	5	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0040086	Abnormal prolactin level	5	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0008213	Gonadotropin deficiency	5	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0000871	Panhypopituitarism	5	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0040086	Abnormal prolactin level	5	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0008213	Gonadotropin deficiency	5	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0000871	Panhypopituitarism	5	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0040086	Abnormal prolactin level	5	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0008213	Gonadotropin deficiency	5	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0000871	Panhypopituitarism	5	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0040086	Abnormal prolactin level	5	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0008213	Gonadotropin deficiency	5	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0000871	Panhypopituitarism	5	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0040086	Abnormal prolactin level	5	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0008213	Gonadotropin deficiency	5	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0000871	Panhypopituitarism	5	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0040086	Abnormal prolactin level	5	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0008213	Gonadotropin deficiency	5	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0000871	Panhypopituitarism	5	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0040086	Abnormal prolactin level	5	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0008213	Gonadotropin deficiency	5	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0000871	Panhypopituitarism	5	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0040086	Abnormal prolactin level	5	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0008213	Gonadotropin deficiency	5	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0000871	Panhypopituitarism	5	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0040086	Abnormal prolactin level	5	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0008213	Gonadotropin deficiency	5	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0000871	Panhypopituitarism	5	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0040086	Abnormal prolactin level	5	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0008213	Gonadotropin deficiency	5	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0000871	Panhypopituitarism	5	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0040086	Abnormal prolactin level	5	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0008213	Gonadotropin deficiency	5	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0000871	Panhypopituitarism	5	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0040086	Abnormal prolactin level	5	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0008213	Gonadotropin deficiency	5	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0000871	Panhypopituitarism	5	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0040086	Abnormal prolactin level	5	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0008213	Gonadotropin deficiency	5	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0000871	Panhypopituitarism	5	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0040086	Abnormal prolactin level	5	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0008213	Gonadotropin deficiency	5	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0000871	Panhypopituitarism	5	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0040086	Abnormal prolactin level	5	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0008213	Gonadotropin deficiency	5	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0000871	Panhypopituitarism	5	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0040086	Abnormal prolactin level	5	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0008213	Gonadotropin deficiency	5	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0000871	Panhypopituitarism	5	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0040086	Abnormal prolactin level	5	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0008213	Gonadotropin deficiency	5	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0000871	Panhypopituitarism	5	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0040086	Abnormal prolactin level	5	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0008213	Gonadotropin deficiency	5	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0000871	Panhypopituitarism	5	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0040086	Abnormal prolactin level	5	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0008213	Gonadotropin deficiency	5	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0000871	Panhypopituitarism	5	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0040086	Abnormal prolactin level	5	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0008213	Gonadotropin deficiency	5	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0000871	Panhypopituitarism	5	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0040086	Abnormal prolactin level	5	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0008213	Gonadotropin deficiency	5	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0000871	Panhypopituitarism	5	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0040086	Abnormal prolactin level	5	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0008213	Gonadotropin deficiency	5	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0000871	Panhypopituitarism	5	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0040086	Abnormal prolactin level	5	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0008213	Gonadotropin deficiency	5	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0000871	Panhypopituitarism	5	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0040086	Abnormal prolactin level	5	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0008213	Gonadotropin deficiency	5	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0000871	Panhypopituitarism	5	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0040086	Abnormal prolactin level	5	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0008213	Gonadotropin deficiency	5	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0000871	Panhypopituitarism	5	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0040086	Abnormal prolactin level	5	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0008213	Gonadotropin deficiency	5	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0000871	Panhypopituitarism	5	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0040086	Abnormal prolactin level	5	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0008213	Gonadotropin deficiency	5	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0000871	Panhypopituitarism	5	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0040086	Abnormal prolactin level	5	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0008213	Gonadotropin deficiency	5	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0000871	Panhypopituitarism	5	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0040086	Abnormal prolactin level	5	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0008213	Gonadotropin deficiency	5	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0000871	Panhypopituitarism	5	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0040086	Abnormal prolactin level	5	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0008213	Gonadotropin deficiency	5	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0000871	Panhypopituitarism	5	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0040086	Abnormal prolactin level	5	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0008213	Gonadotropin deficiency	5	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0000871	Panhypopituitarism	5	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0040086	Abnormal prolactin level	5	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0008213	Gonadotropin deficiency	5	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0000871	Panhypopituitarism	5	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0040086	Abnormal prolactin level	5	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0008213	Gonadotropin deficiency	5	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0000871	Panhypopituitarism	5	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0040086	Abnormal prolactin level	5	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0008213	Gonadotropin deficiency	5	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0000871	Panhypopituitarism	5	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0008232	Elevated circulating follicle stimulating hormone level	5	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0011969	Elevated circulating luteinizing hormone level	5	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0000824	Decreased response to growth hormone stimulation test	5	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0040086	Abnormal prolactin level	5	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0011748	Adrenocorticotropic hormone deficiency	5	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0008213	Gonadotropin deficiency	5	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0000871	Panhypopituitarism	5	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0008245	Pituitary hypothyroidism	5	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0011758	Pituitary acidophilic stem cell adenoma	5	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0008291	Pituitary corticotropic cell adenoma	5	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0011759	Pituitary gonadotropic cell adenoma	5	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0011760	Pituitary growth hormone cell adenoma	5	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0011761	Pituitary null cell adenoma	5	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0006767	Pituitary prolactin cell adenoma	5	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0011762	Pituitary thyrotropic cell adenoma	5	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0012342	Macroprolactinoma	6	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0012341	Microprolactinoma	6	AHI1 CL E G H	54806	220493			ORPHA	0	1194	21575	608894
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0012342	Macroprolactinoma	6	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0012341	Microprolactinoma	6	AHI1 CL E G H	54806	475	Acquired hypoprothrombinemia		ORPHA	0	1194	21575	608894
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0012342	Macroprolactinoma	6	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0012341	Microprolactinoma	6	ARL13B CL E G H	200894	475	Acquired hypoprothrombinemia		ORPHA	0	340	25419	608922
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0012342	Macroprolactinoma	6	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0012341	Microprolactinoma	6	ARL3 CL E G H	403	475	Acquired hypoprothrombinemia		ORPHA	0	137	694	604695
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0012342	Macroprolactinoma	6	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0012341	Microprolactinoma	6	ARMC9 CL E G H	80210	475	Acquired hypoprothrombinemia		ORPHA	0	631	20730	617612
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0012342	Macroprolactinoma	6	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0012341	Microprolactinoma	6	B9D1 CL E G H	27077	475	Acquired hypoprothrombinemia		ORPHA	0	310	24123	614144
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0012342	Macroprolactinoma	6	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0012341	Microprolactinoma	6	BMP4 CL E G H	652	139471			ORPHA	0	197	1071	112262
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0012342	Macroprolactinoma	6	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0012341	Microprolactinoma	6	BRCA1 CL E G H	672	84			ORPHA	0	13955	1100	113705
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0012342	Macroprolactinoma	6	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0012341	Microprolactinoma	6	BRCA2 CL E G H	675	84			ORPHA	0	17543	1101	600185
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0012342	Macroprolactinoma	6	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0012341	Microprolactinoma	6	BRIP1 CL E G H	83990	84			ORPHA	0	5110	20473	605882
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0012342	Macroprolactinoma	6	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0012341	Microprolactinoma	6	CC2D2A CL E G H	57545	2318			ORPHA	0	1525	29253	612013
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0012342	Macroprolactinoma	6	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0012341	Microprolactinoma	6	CC2D2A CL E G H	57545	1454	Common atrioventricular canal	C0221215	ORPHA	0	1525	29253	612013
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0012342	Macroprolactinoma	6	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0012341	Microprolactinoma	6	CEP104 CL E G H	9731	475	Acquired hypoprothrombinemia		ORPHA	0	506	24866	616690
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0012342	Macroprolactinoma	6	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0012341	Microprolactinoma	6	CEP120 CL E G H	153241	220493			ORPHA	0	433	26690	613446
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0012342	Macroprolactinoma	6	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0012341	Microprolactinoma	6	CEP120 CL E G H	153241	475	Acquired hypoprothrombinemia		ORPHA	0	433	26690	613446
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0012342	Macroprolactinoma	6	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0012341	Microprolactinoma	6	CEP290 CL E G H	80184	2318			ORPHA	0	2944	29021	610142
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0012342	Macroprolactinoma	6	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0012341	Microprolactinoma	6	CEP41 CL E G H	95681	220493			ORPHA	0	435	12370	610523
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0012342	Macroprolactinoma	6	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0012341	Microprolactinoma	6	CEP41 CL E G H	95681	475	Acquired hypoprothrombinemia		ORPHA	0	435	12370	610523
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0012342	Macroprolactinoma	6	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0012341	Microprolactinoma	6	CPLANE1 CL E G H	65250	475	Acquired hypoprothrombinemia		ORPHA	0	1989	25801	614571
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0012342	Macroprolactinoma	6	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0012341	Microprolactinoma	6	CSPP1 CL E G H	79848	475	Acquired hypoprothrombinemia		ORPHA	0	1074	26193	611654
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0012342	Macroprolactinoma	6	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0012341	Microprolactinoma	6	ERCC4 CL E G H	2072	84			ORPHA	0	726	3436	133520
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0012342	Macroprolactinoma	6	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0012341	Microprolactinoma	6	FANCA CL E G H	2175	84			ORPHA	0	4396	3582	607139
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0012342	Macroprolactinoma	6	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0012341	Microprolactinoma	6	FANCB CL E G H	2187	84			ORPHA	0	633	3583	300515
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0012342	Macroprolactinoma	6	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0012341	Microprolactinoma	6	FANCC CL E G H	2176	84			ORPHA	0	1743	3584	613899
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0012342	Macroprolactinoma	6	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0012341	Microprolactinoma	6	FANCD2 CL E G H	2177	84			ORPHA	0	1262	3585	613984
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0012342	Macroprolactinoma	6	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0012341	Microprolactinoma	6	FANCE CL E G H	2178	84			ORPHA	0	527	3586	613976
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0012342	Macroprolactinoma	6	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0012341	Microprolactinoma	6	FANCF CL E G H	2188	84			ORPHA	0	434	3587	613897
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0012342	Macroprolactinoma	6	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0012341	Microprolactinoma	6	FANCG CL E G H	2189	84			ORPHA	0	790	3588	602956
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0012342	Macroprolactinoma	6	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0012341	Microprolactinoma	6	FANCI CL E G H	55215	84			ORPHA	0	1506	25568	611360
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0012342	Macroprolactinoma	6	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0012341	Microprolactinoma	6	FANCL CL E G H	55120	84			ORPHA	0	542	20748	608111
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0012342	Macroprolactinoma	6	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0012341	Microprolactinoma	6	FANCM CL E G H	57697	84			ORPHA	0	2045	23168	609644
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0012342	Macroprolactinoma	6	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0012341	Microprolactinoma	6	FOXC1 CL E G H	2296	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	557	3800	601090
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0012342	Macroprolactinoma	6	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0012341	Microprolactinoma	6	FOXE3 CL E G H	2301	88632			ORPHA	0	344	3808	601094
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0012342	Macroprolactinoma	6	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0012341	Microprolactinoma	6	HBB CL E G H	3043	231214			ORPHA	0	1600	4827	141900
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0012342	Macroprolactinoma	6	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0012341	Microprolactinoma	6	HYLS1 CL E G H	219844	475	Acquired hypoprothrombinemia		ORPHA	0	314	26558	610693
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0012342	Macroprolactinoma	6	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0012341	Microprolactinoma	6	INPP5E CL E G H	56623	220493			ORPHA	0	782	21474	613037
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0012342	Macroprolactinoma	6	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0012341	Microprolactinoma	6	INPP5E CL E G H	56623	475	Acquired hypoprothrombinemia		ORPHA	0	782	21474	613037
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0012342	Macroprolactinoma	6	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0012341	Microprolactinoma	6	INPP5E CL E G H	56623	1454	Common atrioventricular canal	C0221215	ORPHA	0	782	21474	613037
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0012342	Macroprolactinoma	6	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0012341	Microprolactinoma	6	KIAA0556 CL E G H	23247	475	Acquired hypoprothrombinemia		ORPHA	0		29068	616650
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0012342	Macroprolactinoma	6	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0012341	Microprolactinoma	6	KIAA0586 CL E G H	9786	475	Acquired hypoprothrombinemia		ORPHA	0	1253	19960	610178
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0012342	Macroprolactinoma	6	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0012341	Microprolactinoma	6	MAD2L2 CL E G H	10459	84			ORPHA	0	121	6764	604094
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0012342	Macroprolactinoma	6	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0012341	Microprolactinoma	6	MKS1 CL E G H	54903	220493			ORPHA	0	839	7121	609883
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0012342	Macroprolactinoma	6	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0012341	Microprolactinoma	6	MKS1 CL E G H	54903	475	Acquired hypoprothrombinemia		ORPHA	0	839	7121	609883
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0012342	Macroprolactinoma	6	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0012341	Microprolactinoma	6	NPHP1 CL E G H	4867	220497			ORPHA	0	815	7905	607100
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0012342	Macroprolactinoma	6	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0012341	Microprolactinoma	6	PALB2 CL E G H	79728	84			ORPHA	0	5225	26144	610355
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0012342	Macroprolactinoma	6	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0012341	Microprolactinoma	6	PIBF1 CL E G H	10464	475	Acquired hypoprothrombinemia		ORPHA	0	180	23352	607532
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0012342	Macroprolactinoma	6	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0012341	Microprolactinoma	6	PITX2 CL E G H	5308	782	Arthrogryposis IUGR thoracic dystrophy		ORPHA	0	221	9005	601542
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0012342	Macroprolactinoma	6	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0012341	Microprolactinoma	6	PITX3 CL E G H	5309	88632			ORPHA	0	54	9006	602669
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0012342	Macroprolactinoma	6	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0012341	Microprolactinoma	6	RAD51 CL E G H	5888	84			ORPHA	0	358	9817	179617
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0012342	Macroprolactinoma	6	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0012341	Microprolactinoma	6	RAD51C CL E G H	5889	84			ORPHA	0	1827	9820	602774
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0012342	Macroprolactinoma	6	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0012341	Microprolactinoma	6	RFWD3 CL E G H	55159	84			ORPHA	0	326	25539	614151
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0012342	Macroprolactinoma	6	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0012341	Microprolactinoma	6	RPGRIP1L CL E G H	23322	220497			ORPHA	0	1494	29168	610937
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0012342	Macroprolactinoma	6	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0012341	Microprolactinoma	6	RPGRIP1L CL E G H	23322	1454	Common atrioventricular canal	C0221215	ORPHA	0	1494	29168	610937
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0012342	Macroprolactinoma	6	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0012341	Microprolactinoma	6	SLX4 CL E G H	84464	84			ORPHA	0	1968	23845	613278
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0012342	Macroprolactinoma	6	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0012341	Microprolactinoma	6	TCTN1 CL E G H	79600	475	Acquired hypoprothrombinemia		ORPHA	0	393	26113	609863
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0012342	Macroprolactinoma	6	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0012341	Microprolactinoma	6	TCTN2 CL E G H	79867	475	Acquired hypoprothrombinemia		ORPHA	0	622	25774	613846
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0012342	Macroprolactinoma	6	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0012341	Microprolactinoma	6	TMEM138 CL E G H	51524	2318			ORPHA	0	166	26944	614459
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0012342	Macroprolactinoma	6	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0012341	Microprolactinoma	6	TMEM216 CL E G H	51259	2318			ORPHA	0	236	25018	613277
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0012342	Macroprolactinoma	6	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0012341	Microprolactinoma	6	TMEM231 CL E G H	79583	2318			ORPHA	0	463	37234	614949
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0012342	Macroprolactinoma	6	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0012341	Microprolactinoma	6	TMEM237 CL E G H	65062	2318			ORPHA	0	466	14432	614423
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0012342	Macroprolactinoma	6	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0012341	Microprolactinoma	6	TMEM237 CL E G H	65062	220497			ORPHA	0	466	14432	614423
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0012342	Macroprolactinoma	6	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0012341	Microprolactinoma	6	TMEM237 CL E G H	65062	475	Acquired hypoprothrombinemia		ORPHA	0	466	14432	614423
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0012342	Macroprolactinoma	6	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0012341	Microprolactinoma	6	TMEM67 CL E G H	91147	475	Acquired hypoprothrombinemia		ORPHA	0	928	28396	609884
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0012342	Macroprolactinoma	6	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0012341	Microprolactinoma	6	TMEM67 CL E G H	91147	1454	Common atrioventricular canal	C0221215	ORPHA	0	928	28396	609884
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0012342	Macroprolactinoma	6	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0012341	Microprolactinoma	6	UBE2T CL E G H	29089	84			ORPHA	0	45	25009	610538
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0012342	Macroprolactinoma	6	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0012341	Microprolactinoma	6	XRCC2 CL E G H	7516	84			ORPHA	0	697	12829	600375
HP:0000864	HP:0033579	Decreased growth hormone responses to growth hormone-releasing hormone challenge	6	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0008240	Secondary growth hormone deficiency	6	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0008202	Reduced circulating prolactin concentration	6	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0012342	Macroprolactinoma	6	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557
HP:0000864	HP:0012341	Microprolactinoma	6	ZNF423 CL E G H	23090	2318			ORPHA	0	810	16762	604557